Proxima Raises $80 Million Led by DCVC to Power the Next Generation of Proximity-Based Medicines
Proxima closes an $80 million seed round backed by DCVC, Nvidia, and others to advance AI drug discovery with an advanced data generation platform.
Three complementary, phase shifting technologies…
…built to unlock the full potential of the proximity modulator modality